comparemela.com

Page 5 - Laura Sutcliffe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sanofi (SNY) Q1 2022 Earnings Call Transcript

SNY earnings call for the period ending March 31, 2022.

Morgan stanleyBrendan ocallaghanPeter verdult citiLaura sutcliffeLuisa hector berenbergSociete generaleThomas triompheFlorent cespedesSanofi pasteurPaul hudsonFlorent cespedes societe generaleJulie van ongevallePeter adamsonEva schaefer jansenOlivier charmeilAmerica merrill lynch

10 Best Pharmaceutical Stocks to Buy in 2022

In this article, we discuss the 10 best pharmaceutical stocks to buy in 2022.

United statesTim chiangRobyn karnauskasMadhu kumarRegeneron pharmaceuticalsHarris associatesRegeneron pharmaceuticals incPartner fund managementAmphastar pharmaceuticals incDynavax technologies corporationGoldman sachsNumber of hedge fund holdersBristol myers squibb companyCollegium pharmaceutical incAmgen incAbbvie inc

GLAXOSMITHKLINE : Gets a Neutral rating from UBS

Laura Sutcliffe from UBS retains his Neutral opinion on the stock. The target price continues to be set at GBX 1680. | February 18, 2022

Laura sutcliffeGlaxosmithkline plc stock exchangePress releaseGbx gsk gb0009252882

Novartis (NVS) Q3 2021 Earnings Call Transcript

NVS earnings call for the period ending September 30, 2021.

United statesSaudi arabiaGraham parryAndrew baumSusanne schaffertLaura sutcliffeHarry kirschSamir shahLilly verzenioAndrew baum citiSeamus fernandez guggenheimSimon baker redburnKeyur parekhSarita kapila morgan stanleySarita kapilaJohn tsai

NOVARTIS AG : Buy rating from UBS | MarketScreener

Laura Sutcliffe from UBS retains his positive opinion on the stock with a Buy rating. Previously set at CHF 95, the target price is lowered to CHF 92. | October 8, 2021

Laura sutcliffeNovartis ag stock exchangePress releaseChf novn ch0012005267

vimarsana © 2020. All Rights Reserved.